Home › Funds › WILKINS INVESTMENT COUNSEL INC › NVS
WILKINS INVESTMENT COUNSEL INC position in NVS
Novartis Ag Sponsored ADR · Health Care
WILKINS INVESTMENT COUNSEL INC reported holding 109,717 shares of NVS (Novartis Ag Sponsored ADR) in its Q3 2026 13F filing — a position valued at US$15.6M, representing 2.05% of its reported portfolio and ranking #19 among its reported holdings. WILKINS INVESTMENT COUNSEL INC has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How WILKINS INVESTMENT COUNSEL INC's NVS position evolved
WILKINS INVESTMENT COUNSEL INC first disclosed a stake in NVS in Q3 2023 at 130,950 shares (US$13.3M). The position peaked in Q3 2024 at 188,056 shares, worth US$21.6M. Across 13 filings, WILKINS INVESTMENT COUNSEL INC increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 109,717 shares valued at US$15.6M — a reduction of -1,350 shares quarter over quarter.. Notable position changes include a 44% increase in Q1 2024 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 130.95K | $13.34M | New |
| Q4 2023 | 130.11K | $13.14M | Reduce |
| Q1 2024 | 187.74K | $18.16M | Add |
| Q2 2024 | 188.97K | $20.12M | Add |
| Q3 2024 | 188.06K | $21.63M | Hold |
| Q4 2024 | 166.78K | $16.23M | Reduce |
| Q1 2025 | 149.31K | $16.65M | Reduce |
| Q2 2025 | 139.42K | $16.87M | Reduce |
| Q3 2025 | 133.98K | $17.18M | Reduce |
| Q4 2025 | 116.41K | $16.05M | Reduce |
| Q1 2026 | 112.68K | $17.21M | Reduce |
| Q2 2026 | 111.07K | $17.41M | Reduce |
| Q3 2026 | 109.72K | $15.64M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (Novartis Ag Sponsored ADR) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 16.76M sh · $2.39B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $938.89M · Q3 2026
- LOOMIS SAYLES & CO L P 4.83M sh · $689.20M · Q3 2026
- NATIXIS ADVISORS, LLC 2.39M sh · $374.02M · Q2 2026
- Cullen Capital Management, LLC 1.95M sh · $278.55M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.72M sh · $250.18M · Q3 2026
More on WILKINS INVESTMENT COUNSEL INC
FAQ
How long has WILKINS INVESTMENT COUNSEL INC held NVS?
WILKINS INVESTMENT COUNSEL INC has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is WILKINS INVESTMENT COUNSEL INC's current position in NVS?
As of Q3 2026, WILKINS INVESTMENT COUNSEL INC holds 109.72K shares of NVS (Novartis Ag Sponsored ADR), valued at $15.64M, representing 2.05% of its reported portfolio and ranking #19.
Has WILKINS INVESTMENT COUNSEL INC been buying or selling NVS?
In the latest 13F filing (Q3 2026), WILKINS INVESTMENT COUNSEL INC reduced its position in NVS. The position peaked in Q3 2024 at 188.06K shares.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.